These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. Takahashi T; Hosoya M; Kimura K; Ohno K; Mori S; Takahashi K; Shigeta S Antiviral Res; 1998 Jan; 37(1):29-35. PubMed ID: 9497070 [TBL] [Abstract][Full Text] [Related]
8. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes. Balzarini J; Lee CK; Schols D; De Clercq E Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194 [TBL] [Abstract][Full Text] [Related]
9. Antiviral effect of ribavirin on Junin virus replication in vitro. Rodríguez M; McCormick JB; Weissenbacher MC Rev Argent Microbiol; 1986; 18(2):69-74. PubMed ID: 2825242 [TBL] [Abstract][Full Text] [Related]
10. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus. Ölschläger S; Neyts J; Günther S Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094 [TBL] [Abstract][Full Text] [Related]
11. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro. Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds. De Clercq E; Cools M; Balzarini J; Snoeck R; Andrei G; Hosoya M; Shigeta S; Ueda T; Minakawa N; Matsuda A Antimicrob Agents Chemother; 1991 Apr; 35(4):679-84. PubMed ID: 2069373 [TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Kirsi JJ; North JA; McKernan PA; Murray BK; Canonico PG; Huggins JW; Srivastava PC; Robins RK Antimicrob Agents Chemother; 1983 Sep; 24(3):353-61. PubMed ID: 6615611 [TBL] [Abstract][Full Text] [Related]
15. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781 [TBL] [Abstract][Full Text] [Related]
16. Intranuclear polypeptides of measles and subacute sclerosing panencephalitis virus-infected cultures. Miller CA Virology; 1980 Feb; 101(1):272-6. PubMed ID: 6766593 [No Abstract] [Full Text] [Related]
17. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication. Jashés M; González M; López-Lastra M; De Clercq E; Sandino A Antiviral Res; 1996 Mar; 29(2-3):309-12. PubMed ID: 8739609 [TBL] [Abstract][Full Text] [Related]
18. A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo. Watanabe M; Hashimoto K; Abe Y; Kodama EN; Nabika R; Oishi S; Ohara S; Sato M; Kawasaki Y; Fujii N; Hosoya M PLoS One; 2016; 11(9):e0162823. PubMed ID: 27612283 [TBL] [Abstract][Full Text] [Related]